Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Reitsma

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Rhinology|October 27, 2025
Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithmE De Corso, M Caminati, P W Hellings, et al.
Rhinology|July 20, 2021
Occupational exposure influences control of disease in patients with chronic rhinosinusitisD A E Dietz de Loos, S Ronsmans, M E Cornet, et al.
Rhinology|July 29, 2020
The Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS): a new CT-based scoring system grading the extent of surgeryS Reitsma, G F J P M Adriaensen, M E Cornet, et al.
Rhinology|April 1, 2020
Executive summary of EPOS 2020 including integrated care pathwaysW J Fokkens, V J Lund, C Hopkins, et al.
Allergy|May 16, 2025
Two-Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory DiseaseH B E Elzinga, J J Otten, M E Cornet, et al.
Rhinology|January 6, 2026
Prevalence of ear complaints in patients with severe chronic rhinosinusitis with nasal polypsH B E Elzinga, J J Otten, R J L van der Lans, et al.
Thrombosis and Haemostasis|September 9, 2011
Endothelial glycocalyx thickness and platelet-vessel wall interactions during atherogenesisS Reitsma, M G A Oude Egbrink, V V T Heijnen, et al.
Rhinology|May 22, 2024
Steroid responsiveness predicts olfactory function recovery in dupilumab treated CRSwNPJ J Otten, R J L van der Lans, L B Benoist, et al.
Rhinology|January 12, 2026
Assessment of the extent of previous endoscopic sinus surgery using the ACCESS score in patients with chronic rhinosinusitis referred to tertiary care rhinologic clinicsM Lazzeroni, R Hoven, E de Corso, et al.
Rhinology|March 13, 2024
Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polypsR van der Lans, J J Otten, G F J P M Adriaensen, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Rhinology|October 27, 2025
Clinical management of dupilumab-induced blood eosinophilia in CRSwNP: a practical algorithmE De Corso, M Caminati, P W Hellings, et al.
Rhinology|July 20, 2021
Occupational exposure influences control of disease in patients with chronic rhinosinusitisD A E Dietz de Loos, S Ronsmans, M E Cornet, et al.
Rhinology|July 29, 2020
The Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS): a new CT-based scoring system grading the extent of surgeryS Reitsma, G F J P M Adriaensen, M E Cornet, et al.
Rhinology|April 1, 2020
Executive summary of EPOS 2020 including integrated care pathwaysW J Fokkens, V J Lund, C Hopkins, et al.
Allergy|May 16, 2025
Two-Year Data of Tapered Dupilumab Shows High Effectiveness in Chronic Rhinosinusitis with Nasal Polyps With Nonsteroidal Anti-inflammatory Drug-Exacerbated Respiratory DiseaseH B E Elzinga, J J Otten, M E Cornet, et al.
Rhinology|January 6, 2026
Prevalence of ear complaints in patients with severe chronic rhinosinusitis with nasal polypsH B E Elzinga, J J Otten, R J L van der Lans, et al.
Thrombosis and Haemostasis|September 9, 2011
Endothelial glycocalyx thickness and platelet-vessel wall interactions during atherogenesisS Reitsma, M G A Oude Egbrink, V V T Heijnen, et al.
Rhinology|May 22, 2024
Steroid responsiveness predicts olfactory function recovery in dupilumab treated CRSwNPJ J Otten, R J L van der Lans, L B Benoist, et al.
Rhinology|January 12, 2026
Assessment of the extent of previous endoscopic sinus surgery using the ACCESS score in patients with chronic rhinosinusitis referred to tertiary care rhinologic clinicsM Lazzeroni, R Hoven, E de Corso, et al.
Rhinology|March 13, 2024
Eosinophils are the dominant type2 marker for the current indication of biological treatment in severe uncontrolled chronic rhinosinusitis with nasal polypsR van der Lans, J J Otten, G F J P M Adriaensen, et al.
Pageof 6